首页> 美国卫生研究院文献>Aging (Albany NY) >Overexpression of Sir2 in the adult fat body is sufficient to extend lifespan of male and female Drosophila
【2h】

Overexpression of Sir2 in the adult fat body is sufficient to extend lifespan of male and female Drosophila

机译:Sir2在成人脂肪体内的过量表达足以延长果蝇的寿命。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sir2 is the most intensively discussed longevity gene in current aging research. Although, the gene encoding for a NAD+-dependent histone deacetylase initially was found to extend lifespan of various organisms ranging from yeast to mammals, serious doubts regarding its role in longevity have been expressed recently. In this study, we tested whether tissue-specific overexpression of Sir2 in the adult fat body can extend lifespan when compared to genetically identical controls. We also wanted to elucidate the mechanisms by which fat body Sir2 promotes longevity by studying the phenotypic and transcriptional changes in the fat body. We found that moderate (3-fold) Sir2 overexpression in the fat body during adulthood only can promote longevity in both sexes by roughly 13 %. In addition, we obtained transcriptional profiles elicited by this overexpression and propose a role for Sir2 in lipid droplet biology especially under conditions of starvation. Furthermore, our data do not support the idea of Sir2 mediating the response to dietary restriction (DR) because transcriptional profiles of fat bodies after DR or Sir2 overexpression do not match. This study provides additional independent evidence for the concept of Sir2 as a longevity gene and as a promising pharmacological target to cure age-related diseases.
机译:Sir2是当前衰老研究中讨论最多的寿命基因。尽管最初发现编码NAD + 依赖的组蛋白脱乙酰基酶的基因延长了从酵母到哺乳动物的各种生物的寿命,但是最近人们对其寿命的作用提出了严重的疑问。在这项研究中,我们测试了与遗传上相同的对照相比,成年脂肪体内Sir2的组织特异性过表达是否可以延长寿命。我们还想通过研究脂肪体的表型和转录变化来阐明脂肪体Sir2促进寿命的机制。我们发现,成年后脂肪体内适度(3倍)Sir2过表达只能使男女寿命延长约13%。此外,我们获得了由这种过表达引起的转录谱,并提出了Sir2在脂质微滴生物学中的作用,尤其是在饥饿条件下。此外,我们的数据不支持Sir2介导饮食限制(DR)反应的想法,因为DR或Sir2过表达后脂肪体的转录谱不匹配。这项研究为Sir2作为长寿基因和有望治愈年龄相关疾病的药理学靶点的概念提供了额外的独立证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号